신신제약

002800KOSDAQ

66.5 / 100

Reference Date: 2026-10-23

Financial Score35.0 / 40

News Sentiment12.5 / 25

Momentum9.0 / 20

Disclosure10.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health and PER is significantly undervalued vs. peers is also solid. Declined 5.8% over the past month, with no recent news.

Company InformationBased on 2025 Annual Report

Business Overview

Shinshin Pharmaceutical specializes in manufacturing and selling OTC medications, particularly topical products for muscle and joint pain. The company primarily sells to pharmacies and wholesale distributors, maintaining direct sales with over 12,000 pharmacies nationwide and actively expanding exports, especially to Southeast Asia.

Number of Employees

369people

Average Salary

59.9M KRW

Score Calculation Basis

Detailed Financial Score

PER

6.83Industry Average 15.008.0Point

Half of industry avg (excellent)

PBR

0.85Industry Average 1.205.5Point

Lower than industry avg (good)

ROE

13.25Industry Average 8.005.5Point

1.7x industry avg (good)

Debt Ratio

3.51Industry Average 100.008.0Point

Half of industry avg (excellent)

Trend 2023~20258.0 / 10 points

Revenue Growth Rate

2.0 / 3

Avg ▲5.3% (2-year basis)

Operating Profit Growth Rate

3.0 / 3

Avg ▲35.7% (2-year basis)

ROE Trend

3.0 / 4

Avg ROE 9.5% (improving, 3yr)

Detailed News Sentiment

0 totalPositive 0Neutral 0Negative 0

Detailed Momentum

52-week position1.0Point

Near 52w low (6%, downtrend)

Current 4,185Won52-week high 6,63052-week low 4,015

1-month return2.0Point

1m -5.85% (slight drop)

Volume trend6.0Point

Volume surge

Detailed Disclosure

0 totalPositive 0Neutral 0Negative 0